Dr. Christophe MALLET

Journal articles

2024

ref_biblio

Rosamaria Lappano, Marcello Maggiolini, Christophe Mallet, Yves Jacquot. Commentary: harnessing the first peptidic modulator of the estrogen receptor GPER. Frontiers in Pharmacology, 2024, 15, pp.1413058. ⟨10.3389/fphar.2024.1413058⟩. ⟨hal-04871148⟩

Accès au texte intégral et bibtex

2023

ref_biblio

Baptiste Jouffre, Alexandre Acramel, Mathilde Belnou, Maria Francesca Santolla, Marianna Talia, et al.. Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action. Scientific Reports, 2023, 13 (1), pp.1326. ⟨10.1038/s41598-023-28062-9⟩. ⟨hal-04087799⟩

Accès au texte intégral et bibtex

ref_biblio

Baptiste Jouffre, Alexandre Acramel, Yves Jacquot, Laurence Daulhac, Christophe Mallet. GPER involvement in inflammatory pain. Steroids, 2023, 200, pp.109311. ⟨10.1016/j.steroids.2023.109311⟩. ⟨hal-04337675⟩

Accès au bibtex

ref_biblio

Christophe Mallet, Jules Desmeules, Rassa Pegahi, Alain Eschalier. An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact. Journal of Pain Research, 2023, 16, pp.1081 – 1094. ⟨10.2147/jpr.s393809⟩. ⟨hal-04337681⟩

Accès au texte intégral et bibtex

ref_biblio

Elodie Picard, Nicolas Kerckhove, Amaury François, Ludivine Boudieu, Elisabeth Billard, et al.. Role of T CD4+ cells, macrophages, C-low threshold mechanoreceptors and spinal Cav3.2 channels in inflammation and related pain-like symptoms in murine inflammatory models. British Journal of Pharmacology, 2023, 180 (4), pp.385-400. ⟨10.1111/bph.15956⟩. ⟨hal-03790651⟩

Accès au bibtex

2022

ref_biblio

Sophie L Fayad, Guillaume Ourties, Benjamin Le Gac, Baptiste Jouffre, Sylvain Lamoine, et al.. Centrally expressed Cav3.2 T-type calcium channel is critical for the initiation and maintenance of neuropathic pain. eLife, 2022, 11, pp.e79018. ⟨10.7554/elife.79018⟩. ⟨hal-03942925⟩

Accès au texte intégral et bibtex

ref_biblio

Vassili Prudhomme, Mélissa Cucca, Lionel Nauton, Elsa Andrieu, Mathilde Fereyrolles, et al.. Design, synthesis and biological evaluation of conformationnally-restricted analogues of E7010 as inhibitors of tubulin assembly (ITA) and vascular disrupting agents (VDA). European Journal of Medicinal Chemistry, 2022, 244, pp.114809. ⟨10.1016/j.ejmech.2022.114809⟩. ⟨hal-03959739⟩

Accès au bibtex

2021

ref_biblio

Johan Å.Nilsson, Christophe Mallet, Kiseko Shionoya, Anders Blomgren, Anders Sundin, et al.. Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity. European Journal of Medicinal Chemistry, 2021, 213, pp.113042. ⟨10.1016/j.ejmech.2020.113042⟩. ⟨hal-04256629⟩

Accès au texte intégral et bibtex

ref_biblio

Christine Courteix, Alain Eschalier, Christophe Mallet. L’évaluation de la douleur chez l’animal de laboratoire. Douleur et Analgésie, 2021, 34 (2), pp.114-122. ⟨10.3166/dea-2021-0145⟩. ⟨hal-03418812⟩

Accès au texte intégral et bibtex

ref_biblio

Christophe Mallet, Ludivine Boudieu, Sylvain Lamoine, Catherine Coudert, Yves Jacquot, et al.. The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice. Frontiers in Endocrinology, 2021, 12, ⟨10.3389/fendo.2021.578250⟩. ⟨hal-04256623⟩

Accès au bibtex

2020

ref_biblio

David André Barrière, Fawzi Boumezbeur, Romain Dalman, Roberto Cadeddu, Damien Richard Richard, et al.. Paracetamol is a centrally acting analgesic using mechanisms located in the periaqueductal grey. British Journal of Pharmacology, 2020, 177 (8), pp.1773-1792. ⟨10.1111/bph.14934⟩. ⟨hal-02380187⟩

Accès au bibtex

2019

ref_biblio

Zoltan Dekan, Setareh Sianati, Arsalan Yousuf, Katy Sutcliffe, Alexander Gillis, et al.. A tetrapeptide class of biased analgesics from an Australian fungus targets the µ-opioid receptor. Proceedings of the National Academy of Sciences of the United States of America, 2019, 116 (44), pp.22353-22358. ⟨10.1073/pnas.1908662116⟩. ⟨hal-04257287⟩

Accès au texte intégral et bibtex

ref_biblio

Nicolas Kerckhove, Ludivine Boudieu, Guillaume Ourties, Justine Bourdier, Laurence Daulhac, et al.. Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors. European Neuropsychopharmacology, 2019, 29, pp.1419 – 1432. ⟨10.1016/j.euroneuro.2019.10.012⟩. ⟨hal-03488870⟩

Accès au texte intégral et bibtex

ref_biblio

Rosamaria Lappano, Christophe Mallet, Bruno Rizzuti, Fedora Grande, Giulia Raffaella Galli, et al.. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells. Cells, 2019, Molecular and Cellular Mechanisms of Cancers: Breast Cancer, 8 (6), pp.590. ⟨10.3390/cells8060590⟩. ⟨hal-02273130⟩

Accès au texte intégral et bibtex

ref_biblio

Elodie Picard, Frédéric Antonio Carvalho, Francina Agosti, Emmanuel Bourinet, Denis Ardid, et al.. Inhibition of Cav3.2 calcium channels: A new target for colonic hypersensitivity associated with low‐grade inflammation. British Journal of Pharmacology, 2019, 176 (7), pp.950-963. ⟨10.1111/bph.14608⟩. ⟨hal-04317223⟩

Accès au texte intégral et bibtex

2018

ref_biblio

Romain Jouve, Vincent Thery, Sylvie Ducki, Julie Helfenbein, Christophe Thiery, et al.. Optimization of the synthesis of a key intermediate for the preparation of glucocorticoids. Steroids, 2018, 137, pp.14 – 21. ⟨10.1016/j.steroids.2018.06.007⟩. ⟨hal-01875170⟩

Accès au bibtex

2016

ref_biblio

Nicolas Kerckhove, Christophe Mallet, Bruno Pereira, Chouki Chenaf, Christian Duale, et al.. Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT—protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial. BMJ Open, 2016, 6 (12), pp.e013530. ⟨10.1136/bmjopen-2016-013530⟩. ⟨hal-04337204⟩

Accès au texte intégral et bibtex

ref_biblio

Christophe Mallet, Claude Dubray, Christian Dualé. FAAH inhibitors in the limelight, but regrettably. International Journal of Clinical Pharmacology and Therapeutics, 2016, 54 (07), pp.498 – 501. ⟨10.5414/cp202687⟩. ⟨hal-04337687⟩

Accès au texte intégral et bibtex

ref_biblio

J. Scanzi, A. Accarie, E. Muller, Bruno Pereira, Y. Aissouni, et al.. Colonic overexpression of the T‐type calcium channel Cav 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients. Neurogastroenterology & Motility, 2016, 28 (11), pp.1632-1640. ⟨10.1111/nmo.12860⟩. ⟨hal-04317301⟩

Accès au bibtex

2015

ref_biblio

Romain Dalmann, Laurence Daulhac, Myriam Antri, Alain Eschalier, Christophe Mallet. Supra-spinal FAAH is required for the analgesic action of paracetamol in an inflammatory context. Neuropharmacology, 2015, 91, pp.63-70. ⟨10.1016/j.neuropharm.2014.11.006⟩. ⟨hal-04326283⟩

Accès au bibtex

2014

ref_biblio

Nicolas Kerckhove, Christophe Mallet, Amaury François, Mathieu Boudes, Jean Chemin, et al.. Cav3.2 calcium channels: the key protagonist of the supraspinal effect of paracetamol. Pain, 2014, 155 (4), pp.764-772. ⟨10.1016/j.pain.2014.01.015⟩. ⟨hal-02356344⟩

Accès au texte intégral et bibtex

ref_biblio

Christophe Mallet, Chouki Chenaf. Prise en charge médicamenteuse de la douleur. Cerveau & psycho. L’essentiel, 2014, 17. ⟨hal-04273988⟩

Accès au bibtex

2013

ref_biblio

David A Barrière, Christophe Mallet, Anders Blomgren, Charlotte Simonsen, Laurence Daulhac, et al.. Fatty Acid Amide Hydrolase-Dependent Generation of Antinociceptive Drug Metabolites Acting on TRPV1 in the Brain. PLoS ONE, 2013, 8 (8), pp.e70690. ⟨10.1371/journal.pone.0070690⟩. ⟨hal-04337223⟩

Accès au texte intégral et bibtex

ref_biblio

Peter M Zygmunt, Anna Ermund, Pouya Movahed, David A Andersson, Charlotte Simonsen, et al.. Monoacylglycerols Activate TRPV1 – A Link between Phospholipase C and TRPV1. PLoS ONE, 2013, 8 (12), pp.e81618. ⟨10.1371/journal.pone.0081618⟩. ⟨hal-04337227⟩

Accès au texte intégral et bibtex

2012

ref_biblio

Christophe Mallet, David Barrière, Alain Eschalier. Le paracétamol : un ancêtre plein d’avenir. Therapies, 2012, 67 (4), pp.277-281. ⟨10.2515/therapie/2012039⟩. ⟨hal-04337690⟩

Accès au bibtex

ref_biblio

Christophe Mallet, Alain Eschalier. Mise au point sur les mécanismes de l’action antalgique du paracétamol. Urgence Pratique, 2012, 115, pp.29-31. ⟨hal-04273935⟩

Accès au bibtex

2011

ref_biblio

Elena Bagley, Jennifer Hacker, Vladimir Chefer, Christophe Mallet, Gavan Mcnally, et al.. Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors. Nature Neuroscience, 2011, 14 (12), pp.1548-1554. ⟨10.1038/nn.2940⟩. ⟨hal-04337230⟩

Accès au bibtex

2010

ref_biblio

David André Barrière, Christophe Mallet, Alain Eschalier. Le paracétamol, de nouvelles cibles pour un vieux médicament. La Lettre de l’Institut UPSA de la Douleur, 2010, 33. ⟨hal-04273458⟩

Accès au bibtex

ref_biblio

Christophe Mallet, David Barrière, Anna Ermund, Bo Jönsson, Alain Eschalier, et al.. TRPV1 in Brain Is Involved in Acetaminophen-Induced Antinociception. PLoS ONE, 2010, 5 (9), pp.e12748. ⟨10.1371/journal.pone.0012748⟩. ⟨hal-04326308⟩

Accès au bibtex

2009

ref_biblio

Macdonald Christie, Christophe Mallet. Endocannabinoids Can Open the Pain Gate. Science Signaling, 2009, 2 (88), ⟨10.1126/scisignal.288pe57⟩. ⟨hal-04337579⟩

Accès au bibtex

2008

ref_biblio

Christophe Mallet, Laurence Daulhac, Jérôme Bonnefont, Catherine Ledent, Monique Etienne, et al.. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain, 2008, 139 (1), pp.190-200. ⟨10.1016/j.pain.2008.03.030⟩. ⟨hal-04326295⟩

Accès au bibtex

2007

ref_biblio

Jérôme Bonnefont, Laurence Daulhac, Monique Etienne, Eric Chapuy, Christophe Mallet, et al.. Acetaminophen recruits spinal p42/p44 mAPKs and GH/IGF-1 receptors to produce analgesia via the serotonergic system. Molecular Pharmacology, 2007, 71 (2), pp.407-415. ⟨10.1124/mol.106.025775⟩. ⟨hal-02659399⟩

Accès au bibtex

2006

ref_biblio

Laurence Daulhac, Christophe Mallet, Christine Courteix, Monique Etienne, Eliane Duroux, et al.. Diabetes-Induced Mechanical Hyperalgesia Involves Spinal Mitogen-Activated Protein Kinase Activation in Neurons and Microglia via N -Methyl-D-aspartate-Dependent Mechanisms. Molecular Pharmacology, 2006, 70 (4), pp.1246-1254. ⟨10.1124/mol.106.025478⟩. ⟨hal-04326273⟩

Accès au bibtex

Conference papers

2021

ref_biblio

Christophe Mallet, David André Barrière, Fouad Boumezbeur, Romain Dalmann, Roberto Cadeddu, et al.. Paracetamol is a centrally acting analgesic using mechanisms located in the periaqueductal grey. Annual Meeting of French Society of Pharmacology and Therapeutics, Jun 2021, Online, France. ⟨hal-03745618⟩

Accès au bibtex

Book sections

2018

ref_biblio

Nicolas Authier, Bénédicte Eschalier, Chouki Chenaf, Marie Zenut, Christophe Mallet, et al.. Traitements de la douleur, Approche pharmacologique. Traité de Médecine (5ème édition), TDM, pp.S10-P01-C11, 2018, 9782901094012. ⟨hal-04273871⟩

Accès au bibtex

2015

ref_biblio

Christophe Mallet, Alain Eschalier. Pharmacology and Mechanism of Action of Acetaminophen. Pharmacology of Pain, IASP press, 2015, 0931092787. ⟨hal-04337640⟩

Accès au bibtex

Poster communications

2019

ref_biblio

Guillaume Ourties, Laurence Daulhac, Alain Eschalier, Emmanuel Bourinet, Christophe Mallet. Involvment of Cav3.2 calcium channels in osteoarthritis pain. European Pain Federation, Krakow Pain School, Jun 2019, Krakow (Cracovie), Poland. ⟨hal-04872989⟩

Accès au bibtex

ref_biblio

Guillaume Ourties, Laurence Daulhac, Alain Eschalier, Christophe Mallet. Involvment of Cav3.2 calcium channels in oesteoarthritis pain. EFIC pain school, Jun 2019, cracovie, Poland. ⟨hal-02363984⟩

Accès au bibtex

Preprints, Working Papers, …

2022

ref_biblio

Sophie L Fayad, Guillaume Ourties, Benjamin Le Gac, Baptiste Jouffre, Sylvain Lamoine, et al.. Centrally expressed Cav3.2 T-type calcium channel is critical for the initiation and maintenance of neuropathic pain. 2022. ⟨hal-03746638⟩

Accès au bibtex